Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 08 Apr 2025

Assessment of competencies of clinical research professionals and proposals to improve clinical research in Portugal

in Drugs Outcomes Research and Policies

Mónica Bogas
Joana Antas
Cátia Magalhães
Mafalda Revige
Liliana Guerra
Cheila Ribeiro
Rita Cunha Eça
Filipa Nunes
Ana Lopes
Luís Costa

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578955

1,283 views

Original Research

Published on 07 Apr 2025

Drug-therapy-related problems and pharmacist interventions in the medical ward in northeast Ethiopia: focus on types, acceptability, and impacts

in Drugs Outcomes Research and Policies

Bedilu Linger Endalifer
Yared Dergu Ayta
Abate Wondesen Tsigie
Yehualashet Teshome Wondmkun
Mekuanint Terefe Kassa
Gedefaw Getnet Amare
Yenesew Wudu Ejigu
Manaye Tamrie Derseh
Abyou Seyfu Ambaye

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558864

718 views

Original Research

Published on 07 Apr 2025

Economic costs and medications for diabetes in older patients in Beijing, China: electronic insurance data analysis

in Drugs Outcomes Research and Policies

Yanhua Ma
Yan Zhao
Ran Wei
Jingtao Qiao
Jingyi Luo
Lina Zhang
Jie Zhang
Mingqun Deng
Yang Yu
Weihao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549244

952 views

Original Research

Published on 03 Apr 2025

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study

in Drugs Outcomes Research and Policies

Firafan Shuma Teka
Ayana Tadesse Korsa
Habte Gebeyehu Bayisa
Dechasa Befikadu W/Senbat
Refisa Shifera Beyene
Dinka Dugassa Iticha
Birbirsa Sefera Senbeta

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1544957

916 views

Original Research

Published on 03 Apr 2025

Argatroban in patients with acute ischemic stroke with early neurological deterioration: a cost-effectiveness analysis from the perspective of Chinese healthcare system

in Drugs Outcomes Research and Policies

Yu Xie
Liping Hu
Ping Xu
Xianbin Guo
Junxiu Cai
Min Pan
Jie Tang
Qingtao Gong
Rong Su
Yake Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1470373

746 views

Original Research

Published on 02 Apr 2025

Development and validation of a Chinese insulin medication literacy scale for patients with diabetes mellitus

in Drugs Outcomes Research and Policies

Fangying Si
Tao Feng
Xiangfen Shi
Sufang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1477050

984 views

Original Research

Published on 02 Apr 2025

Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study

in Drugs Outcomes Research and Policies

Hyein Han
Du Hyun Ro
Hyuk-Soo Han
Sungho Won

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1539328

1,449 views
1 citation

Original Research

Published on 01 Apr 2025

Assessment of Gliflozins prescribing pattern in a United Arab Emirates tertiary-level care hospital

in Drugs Outcomes Research and Policies

Wessa Shenouda
Dixon Thomas
Omar Nabi
Seeba Zachariah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529528

1,282 views

Original Research

Published on 01 Apr 2025

Irisin protects against cerebral ischemia reperfusion injury in a SIRT3-dependent manner

in Drugs Outcomes Research and Policies

Yushuang Cong
Ruichun Guo
Chenglong Li
Qi Li
Sihua Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558457

1,073 views

Original Research

Published on 31 Mar 2025

Specific drugs for rare diseases in a province of eastern China under catalog management: from 2021 to 2023

in Drugs Outcomes Research and Policies

Ruifang Nie
Zhen Zhao
Yahui Zhang
Bo Xu
Wen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1476910

932 views

Original Research

Published on 31 Mar 2025

The clinical assessment of studies on orphan drugs in relation to the EMA’s authorization marketing decisions in Europe

in Drugs Outcomes Research and Policies

Szczepan Jakubowski
Krzysztof Piotr Malinowski
Paweł Kawalec

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558987

1,117 views

Systematic Review

Published on 28 Mar 2025

Factors influencing the cost-effectiveness of novel oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: a systematic review

in Drugs Outcomes Research and Policies

Yan Li
Xintian Wang
Aixia Ma
Pingyu Chen
Hongchao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1441754

1,015 views

Original Research

Published on 26 Mar 2025

An analysis of the clinical application of paliperidone palmitate injection based on real-world

in Drugs Outcomes Research and Policies

Ruixue Liu
Chunxiao Liu
Di Hu
Longkun Wang
Dianwei Feng
Tongxin Guo
Ying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501701

1,276 views

Technology and Code

Published on 26 Mar 2025

Integrating WHO’s digital adaptation kit for antenatal care into BornFyne-PNMS: insights from Cameroon

in Drugs Outcomes Research and Policies

Miriam Nkangu
Brice Tangang
Arthur Pessa
Donald Weledji
Pamela Obegu
Mwenya Kasonde
Ngo V. Ngo
Franck Wanda
Ronald M. Gobina
Odette Kibu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1474999

997 views

Original Research

Published on 26 Mar 2025

Reform progress and achievements of China’s incentive policies for pediatric medicine over the last decade

in Drugs Outcomes Research and Policies

Qiwei Wang
Xing Ling
Zhengli Dai
Xiaoling Wang
Wen Guo
Guiliang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561095

785 views

Brief Research Report

Published on 25 Mar 2025

Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis

in Drugs Outcomes Research and Policies

Borja G. Lopez-Rey
Gerard Carot-Sans
Dan Ouchi
Ferran Torres
Caridad Pontes

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548997

1,257 views